Form
SCHEDULE 13G
Passive or exempt beneficial ownership filing.
Validae Health, L.P. - 31 Mar 2025 SCHEDULE 13G Report for Metsera, Inc. Common Stock (MTSR)
- Filing manager
- Validae Health, L.P.
- Reporting owner
- Christopher Whitten Bernard
- Security
- Metsera, Inc. Common Stock
- Beneficially owned shares
- 13,136,644 shares
- Large-stake signal
-
Ownership
12%Beneficial ownership of this reported class.
Shares
13,136,644 sharesShares beneficially owned as disclosed.
Event date
31 Mar 2025Date tied to the ownership event or amendment.
Accepted by SEC
03 Jun 2025EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 12%
- Symbol
- MTSR
- Shares outstanding
- 105,093,152 shares
- SEC form
- SCHEDULE 13G
- Accepted by SEC
- 03 Jun 2025, 16:30:15 UTC
- Event date
- 31 Mar 2025
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
4 source fields
Key filing fact
Validae Health, L.P. disclosed 12% ownership in Metsera, Inc. Common Stock (MTSR) on 31 Mar 2025.
Key facts
- Validae Health, L.P. filed SCHEDULE 13G for Metsera, Inc. Common Stock (MTSR).
- Disclosed ownership: 12%.
- Date of event: 31 Mar 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 03 Jun 2025, 16:30.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (5)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Validae Health, L.P. | 12% | 12,767,462 | 0 | 12,767,462 | /s/ Christopher Cox | Christopher Cox, President | |
| Population Health Partners GP, LLC | 12% | 12,767,462 | 0 | 12,767,462 | /s/ Christopher Cox | Christopher Cox, Member | |
| Christopher Whitten Bernard | 12% | 13,136,644 | 369,182 | 12,767,462 | /s/ Christopher Whitten Bernard | Christopher Whitten Bernard | |
| Christopher T. Cox | 12% | 12,786,376 | 18,914 | 12,767,462 | /s/ Christopher T. Cox | Christopher T. Cox | |
| Clive A. Meanwell | 12% | 12,834,900 | 67,438 | 12,767,462 | /s/ Clive A. Meanwell | Clive A. Meanwell |
CIK / CUSIP context first